Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).

PMM2-CDG is the most common N-glycosylation defect and shows an increased risk of recurrent and/or severe, sometimes fatal, infections in early life. We hypothesized that natural killer (NK) cells, as important mediators of the immune response against microbial pathogens and regulators of adaptive i...

Full description

Bibliographic Details
Main Authors: Roberto García-López, María Eugenia de la Morena-Barrio, Laia Alsina, Belén Pérez-Dueñas, Jaak Jaeken, Mercedes Serrano, Mercedes Casado, Trinidad Hernández-Caselles
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4944953?pdf=render
_version_ 1819092135494811648
author Roberto García-López
María Eugenia de la Morena-Barrio
Laia Alsina
Belén Pérez-Dueñas
Jaak Jaeken
Mercedes Serrano
Mercedes Casado
Trinidad Hernández-Caselles
author_facet Roberto García-López
María Eugenia de la Morena-Barrio
Laia Alsina
Belén Pérez-Dueñas
Jaak Jaeken
Mercedes Serrano
Mercedes Casado
Trinidad Hernández-Caselles
author_sort Roberto García-López
collection DOAJ
description PMM2-CDG is the most common N-glycosylation defect and shows an increased risk of recurrent and/or severe, sometimes fatal, infections in early life. We hypothesized that natural killer (NK) cells, as important mediators of the immune response against microbial pathogens and regulators of adaptive immunity, might be affected in this genetic disorder.To evaluate possible defects on PMM2-CDG NK peripheral blood cell number, killing activity and expression of membrane receptors.We studied fresh and activated NK cells from twelve PMM2-CDG cells. The number and expression of lymphoid surface receptors were studied by flow cytometry. The NK responsiveness (frequency of degranulated NK cells) and killing activity against K562 target cells was determined in the NK cytotoxicity assay.We found an increase of blood NK cells in three patients with a severe phenotype. Two of them, who had suffered from moderate/severe viral infections during their first year of life, also had reduced T lymphocyte numbers. Patient activated NK cells showed increased expression of CD54 adhesion molecule and NKG2D and NKp46 activating receptors. NKp46 and 2B4 expression was inversely correlated with the expression of NKG2D in activated PMM2-CDG cells. Maximal NK activity against K562 target cells was similar in control and PMM2-CDG cells. Interestingly, the NK cell responsiveness was higher in patient cells. NKG2D and specially CD54 increased surface expression significantly correlated with the increased NK cell cytolytic activity according to the modulation of the killer activity by expression of triggering receptors and adhesion molecules.Our results indicate that hypoglycosylation in PMM2-CDG altered NK cell reactivity against target cells and the expression of CD54 and NKG2D, NKp46 and 2B4 activating receptors during NK cell activation. This suggests a defective control of NK cell killing activity and the overall anti-viral immune response in PMM2-CDG patients. The present work improves our understanding of the immunological functions in PMM2-CDG and possibly in other CDG-I types.
first_indexed 2024-12-21T22:50:48Z
format Article
id doaj.art-5cc0a30f4c5344829357c862cc329535
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T22:50:48Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5cc0a30f4c5344829357c862cc3295352022-12-21T18:47:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01117e015886310.1371/journal.pone.0158863Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).Roberto García-LópezMaría Eugenia de la Morena-BarrioLaia AlsinaBelén Pérez-DueñasJaak JaekenMercedes SerranoMercedes CasadoTrinidad Hernández-CasellesPMM2-CDG is the most common N-glycosylation defect and shows an increased risk of recurrent and/or severe, sometimes fatal, infections in early life. We hypothesized that natural killer (NK) cells, as important mediators of the immune response against microbial pathogens and regulators of adaptive immunity, might be affected in this genetic disorder.To evaluate possible defects on PMM2-CDG NK peripheral blood cell number, killing activity and expression of membrane receptors.We studied fresh and activated NK cells from twelve PMM2-CDG cells. The number and expression of lymphoid surface receptors were studied by flow cytometry. The NK responsiveness (frequency of degranulated NK cells) and killing activity against K562 target cells was determined in the NK cytotoxicity assay.We found an increase of blood NK cells in three patients with a severe phenotype. Two of them, who had suffered from moderate/severe viral infections during their first year of life, also had reduced T lymphocyte numbers. Patient activated NK cells showed increased expression of CD54 adhesion molecule and NKG2D and NKp46 activating receptors. NKp46 and 2B4 expression was inversely correlated with the expression of NKG2D in activated PMM2-CDG cells. Maximal NK activity against K562 target cells was similar in control and PMM2-CDG cells. Interestingly, the NK cell responsiveness was higher in patient cells. NKG2D and specially CD54 increased surface expression significantly correlated with the increased NK cell cytolytic activity according to the modulation of the killer activity by expression of triggering receptors and adhesion molecules.Our results indicate that hypoglycosylation in PMM2-CDG altered NK cell reactivity against target cells and the expression of CD54 and NKG2D, NKp46 and 2B4 activating receptors during NK cell activation. This suggests a defective control of NK cell killing activity and the overall anti-viral immune response in PMM2-CDG patients. The present work improves our understanding of the immunological functions in PMM2-CDG and possibly in other CDG-I types.http://europepmc.org/articles/PMC4944953?pdf=render
spellingShingle Roberto García-López
María Eugenia de la Morena-Barrio
Laia Alsina
Belén Pérez-Dueñas
Jaak Jaeken
Mercedes Serrano
Mercedes Casado
Trinidad Hernández-Caselles
Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
PLoS ONE
title Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
title_full Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
title_fullStr Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
title_full_unstemmed Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
title_short Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
title_sort natural killer cell receptors and cytotoxic activity in phosphomannomutase 2 deficiency pmm2 cdg
url http://europepmc.org/articles/PMC4944953?pdf=render
work_keys_str_mv AT robertogarcialopez naturalkillercellreceptorsandcytotoxicactivityinphosphomannomutase2deficiencypmm2cdg
AT mariaeugeniadelamorenabarrio naturalkillercellreceptorsandcytotoxicactivityinphosphomannomutase2deficiencypmm2cdg
AT laiaalsina naturalkillercellreceptorsandcytotoxicactivityinphosphomannomutase2deficiencypmm2cdg
AT belenperezduenas naturalkillercellreceptorsandcytotoxicactivityinphosphomannomutase2deficiencypmm2cdg
AT jaakjaeken naturalkillercellreceptorsandcytotoxicactivityinphosphomannomutase2deficiencypmm2cdg
AT mercedesserrano naturalkillercellreceptorsandcytotoxicactivityinphosphomannomutase2deficiencypmm2cdg
AT mercedescasado naturalkillercellreceptorsandcytotoxicactivityinphosphomannomutase2deficiencypmm2cdg
AT trinidadhernandezcaselles naturalkillercellreceptorsandcytotoxicactivityinphosphomannomutase2deficiencypmm2cdg